"North Texas pharma innovation tackles the opioid crisis"
Featuring: Dr. Lucas Rodriguez, CEO, CerSci Therapeutics
Opioids are dangerous and addictive, and non-opioid alternatives on the market are plagued with unwanted and dangerous side effects. According to the Centers for Disease Control, 78 people die every day from an overdose of prescription painkillers. Dallas-based CerSci Therapeutics is on the cutting edge of developing the next generation non-opioid pain therapeutics for the treatment and prevention of acute and chronic pain. Learn more about how CerSci’s chemistry and biological targets are leading the way for the development of alternatives to opioids and positioning Dallas as a new hub for growth in the field of health technology.
About the speaker:
Dr. Lucas Rodriguez
co-founded CerSci Therapeutics while completing his PhD requirements in 2015 and 2016. He received his MS and PhD degrees in Biomedical Engineering from the University of Texas at Dallas studying novel bioactive bone cement for orthopedic and craniofacial surgery and new vented dental implant abutments for the mitigation of residual excess dental luting cement in cement-retained crown prosthetics after receiving his BS in biology with a minor in chemistry from Baylor University in 2010. Dr. Rodriguez has extensive experience in design, development, and testing of medical devices and biomedical technologies for commercial applications. He has over 5 years of project management experience in high-tech biomedical and biotherapeutic industries. During graduate school, Dr. Rodriguez pursued a concentration in Innovation and Entrepreneurship at The University of Texas at Dallas Naveen Jindal School of Management. Dr. Rodriguez has experience in start-up development, business model generation, business development, and sales.